Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
US Department of Justice
McKesson
Julphar
Cerilliant
Express Scripts
Healthtrust
Boehringer Ingelheim
Teva

Generated: July 18, 2018

DrugPatentWatch Database Preview

Triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic sources for triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) and what is the scope of triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) freedom to operate?

Triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole)
is the generic ingredient in five branded drugs marketed by G And W Labs, Ortho Mcneil Pharm, Alpharma Us Pharms, Fougera, Perrigo New York, Savage Labs, G And W Labs Inc, and Pharmaderm, and is included in nine NDAs. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole).
Summary for triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole)
US Patents:0
Tradenames:5
Applicants:8
NDAs:9
Drug Master File Entries: 5
DailyMed Link:triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) at DailyMed

US Patents and Regulatory Information for triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmaderm TRIPLE SULFA triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) TABLET;VAGINAL 088462-001 Jan 3, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Alpharma Us Pharms TRIPLE SULFA triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) CREAM;VAGINAL 087864-001 Sep 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Ortho Mcneil Pharm SULTRIN triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) CREAM;VAGINAL 005794-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Fougera TRIPLE SULFA triple sulfa (sulfabenzamide;sulfacetamide;sulfathiazole) CREAM;VAGINAL 086424-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Julphar
Fuji
Chubb
Boehringer Ingelheim
Baxter
Mallinckrodt
Cantor Fitzgerald
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.